2016
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
Which of the following Indian pharmaceutical company has signed a memorandum of agreement for South Africa’s first biosimilars manufacturing facility to be set up at a cost of nearly $91 million.
|
|
Dr. Reddy’s Laboratories
|
|
|
Aurobindo Pharma
|
|
|
Cadila Healthcare
|
|
|
Cipla
|
Explanation:
Detailed explanation-1: -Mumbai-based Cipla will build a biosimilar manufacturing plant in South Africa for SAR1. 3 billion ($89 million)–marking the first such type of a biotech unit outside India for the firm, and in a country where it has extensive operations and goodwill.
There is 1 question to complete.